EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diosmetin Modulates EMT-Associated Plasticity and Fibroblast-Activation Markers in Parallel Breast Cancer In Vitro Models

Monika Michalczyk, Joanna Kubik iD, Aleksandra Józefczyk iD, Magdalena Iwan iD, Ewelina Humeniuk iD, Grzegorz Adamczuk iD, Mariola Michalczuk, Barbara Madej-Czerwonka iD, Maciej Czerwonka iD, Agnieszka Korga-Plewko iD

Molecules · 16.06.2026 · 31 (12) · 2111

DOI: 10.3390/molecules31122111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 16.06.2026. Verfasst von Monika Michalczyk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, Medical University of Lublin, 7 Chodzki Street, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Breast Neoplasms, Flavonoids, Cancer-Associated Fibroblasts. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis remains the leading cause of mortality in breast cancer and is closely linked to epithelial–mesenchymal transition (EMT) and tumor microenvironment (TME)-associated processes. Diosmetin (DT), the active metabolite of diosmin, a widely used venoactive drug, has emerged as a potential anticancer agent. Building on our previous findings demonstrating that DT enhances doxorubicin efficacy, this study investigated its effects on tumor cell plasticity and stromal activation-associated responses. EMT was induced in MCF-7 cells, while a stromal model was established by TGF-β-mediated activation of BJ fibroblasts toward a cancer-associated fibroblast (CAF)-like phenotype. Additionally, doxorubicin-induced senescence was generated in fibroblasts. Migration assays and quantitative real-time PCR were used to assess functional and transcriptional changes. EMT induction resulted in decreased CDH1 expression and increased levels of VIM, MMP2, MMP9, IL-6, and HIF-1A, accompanied by enhanced migratory activity. DT attenuated TGF-β-induced CAF-like activation, as reflected by reduced expression of ACTA2, HGF, MMP2, MMP9, and IL6, and modulated hyaluronan turnover-related genes. Moreover, DT partially alleviated selected senescence-associated features in doxorubicin-treated fibroblasts. Collectively, these findings indicate that DT modulates EMT-associated plasticity and stromal activation-related responses in parallel in vitro models. Given its origin as a metabolite of a clinically used compound and its previously demonstrated chemosensitizing properties, DT may warrant further investigation as a potential adjunctive agent to modulate tumor- and stromal-associated processes in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionBreast NeoplasmsFlavonoidsCancer-Associated FibroblastsFibroblastsCell PlasticityHumansFemaleCell MovementTumor MicroenvironmentMCF-7 CellsTransforming Growth Factor betaDoxorubicinCellular SenescenceGene Expression Regulation, NeoplasticCell Line, Tumor

Stichwörter der Autor:innen

anticancer activitiesbreast cancercancer-associated fibroblastsdiosmetinepithelial–mesenchymal transitionnatural productsenescence

Substanzen

FlavonoidsdiosmetinTransforming Growth Factor betaDoxorubicin

Autor:innen und Institutionen

  • Doctoral School, Medical University of Lublin, 7 Chodzki Street, 20-093 Lublin, Poland.
  • Independent Medical Biology Unit, Faculty of Pharmacy, Medical University of Lublin, 8b Jaczewskiego Street, 20-090 Lublin, Poland.
  • Department of Pharmacognosy with Medicinal Plants Garden, Faculty of Pharmacy, Medical University of Lublin, 1 Chodzki Street, 20-093 Lublin, Poland.
  • Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 6 Chodzki Street, 20-093 Lublin, Poland.
  • Department of Physiology and Toxicology, Institute of Medical Science, Faculty of Medicine, John Paul II Catholic University of Lublin, 1H Konstantynow, 20-708 Lublin, Poland.
  • Human Anatomy Department, Faculty of Medicine, Medical University of Lublin, 4 Jaczewskiego Street, 20-090 Lublin, Poland.

ORCID-Profile: Joanna Kubik, Aleksandra Józefczyk, Magdalena Iwan, Ewelina Humeniuk, Grzegorz Adamczuk, Barbara Madej-Czerwonka, Maciej Czerwonka, Agnieszka Korga-Plewko

Förderung

  • Medical University of Lublin

Zitieren

APA

Michalczyk, M., Kubik, J., Józefczyk, A., Iwan, M., Humeniuk, E., Adamczuk, G., Michalczuk, M., Madej-Czerwonka, B., Czerwonka, M., & Korga-Plewko, A. (2026). Diosmetin Modulates EMT-Associated Plasticity and Fibroblast-Activation Markers in Parallel Breast Cancer In Vitro Models. Molecules, 31(12), 2111. https://doi.org/10.3390/molecules31122111

Vancouver

Michalczyk M, Kubik J, Józefczyk A, Iwan M, Humeniuk E, Adamczuk G, et al. Diosmetin Modulates EMT-Associated Plasticity and Fibroblast-Activation Markers in Parallel Breast Cancer In Vitro Models. Molecules. 2026;31(12):2111. doi:10.3390/molecules31122111

BibTeX
@article{Michalczyk2026,
  author = {Michalczyk, Monika and Kubik, Joanna and Józefczyk, Aleksandra and Iwan, Magdalena and Humeniuk, Ewelina and Adamczuk, Grzegorz and Michalczuk, Mariola and Madej-Czerwonka, Barbara and Czerwonka, Maciej and Korga-Plewko, Agnieszka},
  title = {Diosmetin Modulates EMT-Associated Plasticity and Fibroblast-Activation Markers in Parallel Breast Cancer In Vitro Models},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {12},
  pages = {2111},
  doi = {10.3390/molecules31122111}
}
Kostenlos starten →